Medium | Share Count
The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.
Affected: AARD, ABOS, ACET, ACON, AEI, AQMS, ARTL, ASNS, ATOS, AVCRF, BCYC, BDMD and 133 more
A filing-first public record from Lucide House.
Issue 015 | U.S. Pilot | 2026-11-01
Mary found 145 U.S. candidates. This issue publishes only the visible register rows and their source-linked company pages.
These are the issue-visible rows. Each published company page stays source-linked and only renders when the row is part of the public register.
Mary run: 96f10914845d4a63bf1f2ca5985451b2 | as of 2026-10-30 | PARTIAL_SUCCESS
Meaningful register changes are shown below; unchanged passing companies remain in the Register.
| Ticker | Company | Change | Reason | Filing |
|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | New Entrant | Entered the current register. | Open Filing |
| AEI | Alset Inc. | New Entrant | Entered the current register. | Open Filing |
| AQMS | Aqua Metals, Inc. | New Entrant | Entered the current register. | Open Filing |
| ATOS | ATOSSA THERAPEUTICS, INC. | New Entrant | Entered the current register. | Open Filing |
| CRBU | Caribou Biosciences, Inc. | New Entrant | Entered the current register. | Open Filing |
| DCGO | DocGo Inc. | New Entrant | Entered the current register. | Open Filing |
| HCAI | Huachen AI Parking Management Technology Holding Co., Ltd | New Entrant | Entered the current register. | Open Filing |
| KPRX | KIORA PHARMACEUTICALS INC | New Entrant | Entered the current register. | Open Filing |
| MTVA | MetaVia Inc. | New Entrant | Entered the current register. | Open Filing |
| PMN | ProMIS Neurosciences Inc. | New Entrant | Entered the current register. | Open Filing |
| SLE | Super League Enterprise, Inc. | New Entrant | Entered the current register. | Open Filing |
| BCYC | BICYCLE THERAPEUTICS PLC | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| BDMD | Baird Medical Investment Holdings Ltd | Needs Review | Newly visible with a disclosed review state. | Open Filing |
| BIYA | Baiya International Group Inc. | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| HXHX | Haoxin Holdings Ltd | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| LX | LexinFintech Holdings Ltd. | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| MI | NFT Ltd | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| RR | RICHTECH ROBOTICS INC. | Needs Review | Newly visible with a disclosed review state. | Open Filing |
| VISN | Vistance Networks, Inc. | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| YDKG | Yueda Digital Holding | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| YOUL | Youlife Group Inc. | Needs Review | Changed from passing to a disclosed review state. | Open Filing |
| ADVB | Advanced Biomed Inc. | Exit | Exited the current register. | Open Filing |
| APRE | Aprea Therapeutics, Inc. | Exit | Exited the current register. | Open Filing |
| APVO | Aptevo Therapeutics Inc. | Exit | Exited the current register. | Open Filing |
| ARBB | ARB IOT Group Ltd | Exit | Exited the current register. | Open Filing |
| ASBP | Aspire Biopharma Holdings, Inc. | Exit | Exited the current register. | Open Filing |
| ATPC | Agape ATP Corp | Exit | Exited the current register. | Open Filing |
| ATYR | aTYR PHARMA INC | Exit | Exited the current register. | Open Filing |
| AUUD | AUDDIA INC. | Exit | Exited the current register. | Open Filing |
| AXG | Solowin Holdings, Ltd. | Exit | Exited the current register. | Open Filing |
| AZTR | Azitra, Inc. | Exit | Exited the current register. | Open Filing |
| BBLG | Bone Biologics Corp | Exit | Exited the current register. | Open Filing |
| BIOA | BioAge Labs, Inc. | Exit | Exited the current register. | Open Filing |
| BIVI | BIOVIE INC. | Exit | Exited the current register. | Open Filing |
| BJDX | Bluejay Diagnostics, Inc. | Exit | Exited the current register. | Open Filing |
| BON | Bon Natural Life Ltd | Exit | Exited the current register. | Open Filing |
| BRNS | Barinthus Biotherapeutics plc. | Exit | Exited the current register. | Open Filing |
| BTCT | BTC Digital Ltd. | Exit | Exited the current register. | Open Filing |
| CENN | Cenntro Inc. | Exit | Exited the current register. | Open Filing |
| CHR | Cheer Holding, Inc. | Exit | Exited the current register. | Open Filing |
| CNEY | CN ENERGY GROUP. INC. | Exit | Exited the current register. | Open Filing |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Exit | Exited the current register. | Open Filing |
| CRKN | Crown Electrokinetics Corp. | Exit | Exited the current register. | Open Filing |
| CTNT | CHEETAH NET SUPPLY CHAIN SERVICE INC. | Exit | Exited the current register. | Open Filing |
| DCOY | Decoy Therapeutics Inc. | Exit | Exited the current register. | Open Filing |
| DCX | Digital Currency X Technology Inc. | Exit | Exited the current register. | Open Filing |
| DSWL | DESWELL INDUSTRIES INC | Exit | Exited the current register. | Open Filing |
| DUO | Fangdd Network Group Ltd. | Exit | Exited the current register. | Open Filing |
| EBON | Ebang International Holdings Inc. | Exit | Exited the current register. | Open Filing |
| ENFY | Enlightify Inc. | Exit | Exited the current register. | Open Filing |
| ERNA | Ernexa Therapeutics Inc. | Exit | Exited the current register. | Open Filing |
| EVGN | Evogene Ltd. | Exit | Exited the current register. | Open Filing |
| FAMI | Farmmi, Inc. | Exit | Exited the current register. | Open Filing |
| FLYE | Fly-E Group, Inc. | Exit | Exited the current register. | Open Filing |
| GDHG | GOLDEN HEAVEN GROUP HOLDINGS LTD. | Exit | Exited the current register. | Open Filing |
| GFR | Greenfire Resources Ltd. | Exit | Exited the current register. | Open Filing |
| GIGM | GIGAMEDIA Ltd | Exit | Exited the current register. | Open Filing |
| GLPG | GALAPAGOS NV | Exit | Exited the current register. | Open Filing |
| GRI | GRI Bio, Inc. | Exit | Exited the current register. | Open Filing |
| GVH | Globavend Holdings Ltd | Exit | Exited the current register. | Open Filing |
| HIHO | HIGHWAY HOLDINGS LTD | Exit | Exited the current register. | Open Filing |
| HKIT | HiTek Global Inc. | Exit | Exited the current register. | Open Filing |
| HKPD | Cellyan Biotechnology Co., Ltd | Exit | Exited the current register. | Open Filing |
| HOOK | HOOKIPA Pharma Inc. | Exit | Exited the current register. | Open Filing |
| IBIO | iBio, Inc. | Exit | Exited the current register. | Open Filing |
| IMUX | IMMUNIC, INC. | Exit | Exited the current register. | Open Filing |
| INTJ | Intelligent Group Ltd | Exit | Exited the current register. | Open Filing |
| IVDA | Iveda Solutions, Inc. | Exit | Exited the current register. | Open Filing |
| JYD | Jayud Global Logistics Ltd | Exit | Exited the current register. | Open Filing |
| JZXN | Jiuzi Holdings, Inc. | Exit | Exited the current register. | Open Filing |
| KALA | KALA BIO, Inc. | Exit | Exited the current register. | Open Filing |
| KAVL | Kaival Brands Innovations Group, Inc. | Exit | Exited the current register. | Open Filing |
| KTTA | Pasithea Therapeutics Corp. | Exit | Exited the current register. | Open Filing |
| LGCB | Linkage Global Inc | Exit | Exited the current register. | Open Filing |
| LGCL | Lucas GC Ltd | Exit | Exited the current register. | Open Filing |
| LGMK | LogicMark, Inc. | Exit | Exited the current register. | Open Filing |
| LICN | Lichen International Ltd | Exit | Exited the current register. | Open Filing |
| LUCYW | Innovative Eyewear Inc | Exit | Exited the current register. | Open Filing |
| MEGL | Magic Empire Global Ltd | Exit | Exited the current register. | Open Filing |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | Exit | Exited the current register. | Open Filing |
| MWG | Multi Ways Holdings Ltd | Exit | Exited the current register. | Open Filing |
| NIVFW | NewGenIvf Group Ltd | Exit | Exited the current register. | Open Filing |
| NNOX | Nano-X Imaging Ltd. | Exit | Exited the current register. | Open Filing |
| NUWE | Nuwellis, Inc. | Exit | Exited the current register. | Open Filing |
| OCG | Oriental Culture Holding LTD | Exit | Exited the current register. | Open Filing |
| ORIS | ORIENTAL RISE HOLDINGS Ltd | Exit | Exited the current register. | Open Filing |
| PHIO | Phio Pharmaceuticals Corp. | Exit | Exited the current register. | Open Filing |
| PRFX | PRF Technologies Ltd. | Exit | Exited the current register. | Open Filing |
| PTPI | Petros Pharmaceuticals, Inc. | Exit | Exited the current register. | Open Filing |
| RAYA | Erayak Power Solution Group Inc. | Exit | Exited the current register. | Open Filing |
| RITR | Reitar Logtech Holdings Ltd | Exit | Exited the current register. | Open Filing |
| RNAZ | Transcode Therapeutics, Inc. | Exit | Exited the current register. | Open Filing |
| RVSN | Rail Vision Ltd. | Exit | Exited the current register. | Open Filing |
| SBFM | Sunshine Biopharma Inc. | Exit | Exited the current register. | Open Filing |
| SHFS | SHF Holdings, Inc. | Exit | Exited the current register. | Open Filing |
| SILEF | Silver Elephant Mining Corp. | Exit | Exited the current register. | Open Filing |
| SNSE | Sensei Biotherapeutics, Inc. | Exit | Exited the current register. | Open Filing |
| SOBR | SOBR Safe, Inc. | Exit | Exited the current register. | Open Filing |
| SOPA | SOCIETY PASS INCORPORATED. | Exit | Exited the current register. | Open Filing |
| SOS | SOS Ltd | Exit | Exited the current register. | Open Filing |
| SUGP | SU Group Holdings Ltd | Exit | Exited the current register. | Open Filing |
| SVA | SINOVAC BIOTECH LTD | Exit | Exited the current register. | Open Filing |
| SXTC | China SXT Pharmaceuticals, Inc. | Exit | Exited the current register. | Open Filing |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | Exit | Exited the current register. | Open Filing |
| TAOP | Taoping Inc. | Exit | Exited the current register. | Open Filing |
| TIRXF | TIAN RUIXIANG HOLDINGS LTD | Exit | Exited the current register. | Open Filing |
| TNXP | Tonix Pharmaceuticals Holding Corp. | Exit | Exited the current register. | Open Filing |
| TWAV | TaoWeave, Inc. | Exit | Exited the current register. | Open Filing |
| TWG | Top Wealth Group Holding Ltd | Exit | Exited the current register. | Open Filing |
| UOKA | MDJM LTD | Exit | Exited the current register. | Open Filing |
| UPC | Universe Pharmaceuticals INC | Exit | Exited the current register. | Open Filing |
| UTSI | UTSTARCOM HOLDINGS CORP. | Exit | Exited the current register. | Open Filing |
| VCIG | VCI Global Ltd | Exit | Exited the current register. | Open Filing |
| WAI | Top KingWin Ltd | Exit | Exited the current register. | Open Filing |
| WHLM | Wilhelmina International, Inc. | Exit | Exited the current register. | Open Filing |
| WIMI | WiMi Hologram Cloud Inc. | Exit | Exited the current register. | Open Filing |
| WLDS | Wearable Devices Ltd. | Exit | Exited the current register. | Open Filing |
| XBIO | Xenetic Biosciences, Inc. | Exit | Exited the current register. | Open Filing |
| ZCMD | Zhongchao Inc. | Exit | Exited the current register. | Open Filing |
One list. Source state first. Filing one click away when available.
Swipe horizontally to inspect statement evidence, filing details, and source state.
| Ticker | Company | Screen State | Internal NCAV Discount | NCAV | Statement Evidence | Filing | Source State | Action |
|---|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | Passing | 63.8% | 81,976,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| ABOS | Acumen Pharmaceuticals, Inc. | Passing | 82.6% | 86,941,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-12 Open Filing |
Verified | Inspect |
| ACET | Adicet Bio, Inc. | Needs Review | 74.3% | 127,781,000 |
Negative OCF
Share Count Reduced
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-K 2026-05-20 Open Filing |
Needs Review | Inspect |
| ACON | Aclarion, Inc. | Passing | 74.1% | 18,390,343 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| AEI | Alset Inc. | Passing | 36.6% | 31,310,403 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| AQMS | Aqua Metals, Inc. | Passing | 38.0% | 7,102,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| ARTL | ARTELO BIOSCIENCES, INC. | Passing | 67.3% | 4,575,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| ASNS | ACTELIS NETWORKS INC | Passing | 84.4% | 6,933,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| ATOS | ATOSSA THERAPEUTICS, INC. | Passing | 36.0% | 29,211,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-08 Open Filing |
Verified | Inspect |
| AVCRF | Avricore Health Inc. | Needs Review | 90.9% | 895,255 |
NCAV Growing
Positive OCF
|
20-F 2025-06-16 Open Filing |
Stale Filing | Inspect |
| BCYC | BICYCLE THERAPEUTICS PLC | Needs Review | 51.0% | 521,059,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-04-30 Open Filing |
Stale Filing | Inspect |
| BDMD | Baird Medical Investment Holdings Ltd | Needs Review | 70.2% | 16,492,045 |
High NCAV Burn since the previous filing
Material 1Y Share Increase
+2 more
More statement observations
Negative OCF
latest reporting-period cash from operations < 0
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-24 Open Filing |
Stale Filing | Inspect |
| BIYA | Baiya International Group Inc. | Needs Review | 93.2% | 21,588,727 |
Negative OCF
NCAV Growing
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-30 Open Filing |
Stale Filing | Inspect |
| BLMZF | Harrison Global Holdings Inc. | Needs Review | 91.3% | 2,324,561 |
Negative OCF
Low Debt
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-02-14 Open Filing |
Stale Filing | Inspect |
| BRQSF | Borqs Technologies, Inc. | Passing | 48.8% | 6,898,000 |
Material 1Y Share Increase
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-15 Open Filing |
Verified | Inspect |
| BYAH | Park Ha Biological Technology Co., Ltd. | Needs Review | 63.3% | 3,544,201 |
NCAV Growing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-15 Open Filing |
Needs Review | Inspect |
| CAMG | CAM GROUP, INC. | Needs Review | 99.7% | 7,752,030 |
Positive OCF
|
10-Q 2015-05-20 Open Filing |
Stale Filing | Inspect |
| CDTG | CDT Environmental Technology Investment Holdings Ltd | Passing | 51.2% | 26,053,185 |
Material 1Y Share Increase
Negative OCF
+1 more
More statement observations
Current Ratio <= 1.5
current assets / current liabilities <= 1.5
|
20-F 2026-05-15 Open Filing |
Verified | Inspect |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | Passing | 57.9% | 5,751,270 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-08 Open Filing |
Verified | Inspect |
| CISS | C3is Inc. | Needs Review | 98.1% | 17,451,693 |
Positive OCF
Share Count Reduced
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-22 Open Filing |
Stale Filing | Inspect |
| CNTX | Context Therapeutics Inc. | Passing | 66.5% | 51,860,098 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-06 Open Filing |
Verified | Inspect |
| CODX | Co-Diagnostics, Inc. | Passing | 69.4% | 4,324,935 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| CRBU | Caribou Biosciences, Inc. | Passing | 45.6% | 75,401,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| CREG | Smart Powerr Corp. | Passing | 100.0% | 146,916,120 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| CYN | Cyngn Inc. | Passing | 88.1% | 39,539,710 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| DCGO | DocGo Inc. | Passing | 39.2% | 40,149,316 |
High NCAV Burn since the previous filing
Negative OCF
+2 more
More statement observations
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-11 Open Filing |
Verified | Inspect |
| DDI | DoubleDown Interactive Co., Ltd. | Needs Review | 92.4% | 437,417,000 |
NCAV Growing
Positive OCF
+2 more
More statement observations
No Material 1Y Share Increase
1Y share change > -2% and <= +1% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-03-31 Open Filing |
Stale Filing | Inspect |
| DOYU | DouYu International Holdings Ltd | Needs Review | 50.9% | 225,089,902 |
High NCAV Burn since the previous filing
Negative OCF
+2 more
More statement observations
No Material 1Y Share Increase
1Y share change > -2% and <= +1% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-17 Open Filing |
Stale Filing | Inspect |
| DTST | Data Storage Corp | Passing | 38.7% | 10,531,257 |
High NCAV Burn since the previous filing
Negative OCF
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| ECIA | ENCISION INC | Needs Review | 41.2% | 254,900 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2025-11-13 Open Filing |
Stale Filing | Inspect |
| EH | EHang Holdings Ltd | Passing | 99.4% | 84,119,805 |
High NCAV Burn since the previous filing
Material 1Y Share Increase
+2 more
More statement observations
Negative OCF
latest reporting-period cash from operations < 0
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-15 Open Filing |
Verified | Inspect |
| EHTH | eHealth, Inc. | Passing | 85.5% | 105,150,000 |
Positive OCF
Current Ratio > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| EJH | E-Home Household Service Holdings Ltd | Needs Review | 97.4% | 198,872,029 |
Material 1Y Share Increase
Negative OCF
+2 more
More statement observations
NCAV Growing
equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-10-30 Open Filing |
Stale Filing | Inspect |
| ENGN | enGene Holdings Inc. | Passing | 52.9% | 217,644,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-06-15 Open Filing |
Verified | Inspect |
| ENLV | Enlivex Ltd. | Needs Review | 68.7% | 1,351,128,000 |
Material 1Y Share Increase
Negative OCF
+2 more
More statement observations
NCAV Growing
equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-03-25 Open Filing |
Stale Filing | Inspect |
| ENVB | Enveric Biosciences, Inc. | Passing | 45.1% | 4,914,423 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| ESMC | ESCALON MEDICAL CORP | Passing | 58.0% | 3,180,628 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| EYPT | EyePoint, Inc. | Passing | 84.8% | 191,759,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| FBIO | Fortress Biotech, Inc. | Passing | 54.8% | 140,980,000 |
Positive OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| FCHL | Fitness Champs Holdings Ltd | Needs Review | 72.9% | 124,252 |
Current Ratio <= 1.5
Positive OCF
+1 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
|
20-F 2026-05-22 Open Filing |
Needs Review | Inspect |
| FCUV | FOCUS UNIVERSAL INC. | Passing | 46.1% | 6,216,054 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| FLNA | FILANA THERAPEUTICS, INC. | Passing | 37.3% | 47,738,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| FTFT | Future FinTech Group Inc. | Passing | 62.8% | 41,141,257 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| GENI | Genius Sports Ltd | Needs Review | 55.8% | 143,871,000 |
NCAV Growing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-03-17 Open Filing |
Stale Filing | Inspect |
| GERN | GERON CORP | Passing | 99.7% | 193,519,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-06 Open Filing |
Verified | Inspect |
| GLXG | Galaxy Payroll Group Ltd | Needs Review | 68.8% | 3,276,838 |
Negative OCF
Share Count Reduced
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-10-24 Open Filing |
Stale Filing | Inspect |
| GMTH | GMTech Inc. | Needs Review | 99.2% | 424,430 |
NCAV Growing
Positive OCF
+2 more
More statement observations
No Material 1Y Share Increase
1Y share change > -2% and <= +1% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-K 2026-03-06 Open Filing |
Stale Filing | Inspect |
| GNLN | Greenlane Holdings, Inc. | Passing | 51.8% | 13,834,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| GNTA | Genenta Science S.p.A. | Needs Review | 35.0% | 22,288,317 |
Material 1Y Share Increase
Negative OCF
+2 more
More statement observations
NCAV Growing
equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-01 Open Filing |
Stale Filing | Inspect |
| GTEC | Greenland Technologies Holding Corp. | Passing | 74.3% | 54,914,268 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| GXAI | GAXOS.AI INC. | Needs Review | 61.1% | 11,587,582 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-19 Open Filing |
Needs Review | Inspect |
| HAO | Haoxi Health Technology Ltd | Needs Review | 70.1% | 15,385,676 |
Negative OCF
NCAV Growing
+3 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-10-20 Open Filing |
Stale Filing | Inspect |
| HCAI | Huachen AI Parking Management Technology Holding Co., Ltd | Passing | 44.8% | 5,160,874 |
High NCAV Burn since the previous filing
Negative OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-13 Open Filing |
Verified | Inspect |
| HOLO | MicroCloud Hologram Inc. | Needs Review | 93.8% | 404,391,818 |
NCAV Growing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-03-27 Open Filing |
Stale Filing | Inspect |
| HUDI | Huadi International Group Co., Ltd. | Needs Review | 80.1% | 36,576,007 |
High NCAV Burn since the previous filing
Negative OCF
+3 more
More statement observations
No Material 1Y Share Increase
1Y share change > -2% and <= +1% using the same share-count source
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-01-30 Open Filing |
Stale Filing | Inspect |
| HXHX | Haoxin Holdings Ltd | Needs Review | 90.3% | 23,143,718 |
Material 1Y Share Increase
Negative OCF
+2 more
More statement observations
NCAV Growing
equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-30 Open Filing |
Stale Filing | Inspect |
| ILLMF | illumin Holdings Inc. | Needs Review | 58.0% | 60,925,246 |
High NCAV Burn since the previous filing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
40-F 2023-03-09 Open Filing |
Stale Filing | Inspect |
| IMA | ImageneBio, Inc. | Passing | 57.7% | 108,651,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| INAB | IN8BIO, INC. | Passing | 53.7% | 19,178,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| INBP | INTEGRATED BIOPHARMA INC | Passing | 48.6% | 10,287,000 |
High NCAV Burn since the previous filing
Positive OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-08 Open Filing |
Verified | Inspect |
| INFQ | Infleqtion, Inc. | Passing | 64.6% | 437,520,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| INLF | INLIF Ltd | Needs Review | 87.7% | 9,588,410 |
Negative OCF
NCAV Growing
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-03-06 Open Filing |
Stale Filing | Inspect |
| INVE | Identiv, Inc. | Passing | 49.5% | 128,433,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| ITP | IT TECH PACKAGING, INC. | Needs Review | 83.2% | 12,115,709 |
Positive OCF
Low Debt
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2025-11-13 Open Filing |
Stale Filing | Inspect |
| IXHL | Incannex Healthcare Inc. | Passing | 54.1% | 75,046,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| IZM | ICZOOM Group Inc. | Needs Review | 45.3% | 14,398,948 |
Material 1Y Share Increase
Positive OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-10-24 Open Filing |
Stale Filing | Inspect |
| JDZG | JIADE Ltd | Needs Review | 97.3% | 9,710,651 |
Negative OCF
NCAV Growing
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-10 Open Filing |
Stale Filing | Inspect |
| JTAI | Jet.AI Inc. | Passing | 95.1% | 10,600,641 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| KPRX | KIORA PHARMACEUTICALS INC | Passing | 45.3% | 11,390,320 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-08 Open Filing |
Verified | Inspect |
| KUBR | Kuber Resources Corp | Needs Review | 98.7% | 9,388,127 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2025-11-19 Open Filing |
Stale Filing | Inspect |
| LAB | STANDARD BIOTOOLS INC. | Passing | 46.3% | 443,462,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-06 Open Filing |
Verified | Inspect |
| LENZ | LENZ Therapeutics, Inc. | Passing | 60.5% | 242,324,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-11 Open Filing |
Verified | Inspect |
| LIANY | LianBio | Needs Review | 98.0% | 231,015,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2023-11-13 Open Filing |
Stale Filing | Inspect |
| LIDR | AEye, Inc. | Passing | 37.6% | 71,858,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| LIFD | LFTD PARTNERS INC. | Passing | 61.9% | 4,281,654 |
High NCAV Burn since the previous filing
Positive OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| LIPO | LIPELLA PHARMACEUTICALS INC. | Needs Review | 99.8% | 1,217,073 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2025-11-14 Open Filing |
Stale Filing | Inspect |
| LPCN | Lipocine Inc. | Passing | 52.6% | 22,717,091 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| LX | LexinFintech Holdings Ltd. | Needs Review | 79.8% | 1,067,386,164 |
Material 1Y Share Increase
NCAV Growing
+3 more
More statement observations
Positive OCF
latest reporting-period cash from operations > 0
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-29 Open Filing |
Stale Filing | Inspect |
| MGX | Metagenomi Therapeutics, Inc. | Passing | 65.6% | 85,390,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-11 Open Filing |
Verified | Inspect |
| MI | NFT Ltd | Needs Review | 94.3% | 99,684,186 |
Material 1Y Share Increase
Negative OCF
+2 more
More statement observations
NCAV Growing
equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-01 Open Filing |
Stale Filing | Inspect |
| MLGO | MicroAlgo Inc. | Needs Review | 94.4% | 353,045,517 |
NCAV Growing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-01 Open Filing |
Stale Filing | Inspect |
| MSAI | MultiSensor AI Holdings, Inc. | Passing | 74.1% | 25,327,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| MSN | EMERSON RADIO CORP | Needs Review | 62.7% | 18,049,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-02-17 Open Filing |
Stale Filing | Inspect |
| MTVA | MetaVia Inc. | Passing | 34.6% | 8,847,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| NEON | Neonode Inc. | Passing | 50.5% | 22,366,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| NNDM | Nano Dimension Ltd. | Passing | 99.9% | 417,634,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| NPK | NATIONAL PRESTO INDUSTRIES INC | Passing | 99.6% | 299,774,000 |
Positive OCF
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| NPWR | NET Power Inc. | Passing | 75.1% | 286,115,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-11 Open Filing |
Verified | Inspect |
| NSPR | InspireMD, Inc. | Passing | 41.0% | 35,740,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| NTCL | NetClass Technology Inc | Needs Review | 99.6% | 1,026,563 |
High NCAV Burn since the previous filing
Negative OCF
+2 more
More statement observations
Current Ratio <= 1.5
current assets / current liabilities <= 1.5
No Material 1Y Share Increase
1Y share change > -2% and <= +1% using the same share-count source
|
20-F 2026-02-02 Open Filing |
Stale Filing | Inspect |
| NVNO | enVVeno Medical Corp | Passing | 80.9% | 23,139,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-06 Open Filing |
Verified | Inspect |
| NXTS | Nexentis Technologies Inc. | Passing | 90.9% | 4,685,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| OGEN | ORAGENICS INC | Passing | 73.8% | 6,181,758 |
High NCAV Burn since the previous filing
Negative OCF
|
10-Q 2026-05-08 Open Filing |
Verified | Inspect |
| OKUR | OnKure Therapeutics, Inc. | Passing | 80.4% | 183,141,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-05 Open Filing |
Verified | Inspect |
| PBM | PSYENCE BIOMEDICAL LTD. | Needs Review | 68.5% | 5,965,908 |
Negative OCF
Share Count Reduced
|
20-F 2025-07-25 Open Filing |
Stale Filing | Inspect |
| PETZ | TDH Holdings, Inc. | Needs Review | 47.8% | 24,536,353 |
Negative OCF
NCAV Growing
+2 more
More statement observations
No Material 1Y Share Increase
1Y share change > -2% and <= +1% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-20 Open Filing |
Stale Filing | Inspect |
| PEVM | PHOENIX MOTOR INC. | Needs Review | 99.3% | 1,885,000 |
High NCAV Burn since the previous filing
Negative OCF
+2 more
More statement observations
Current Ratio <= 1.5
current assets / current liabilities <= 1.5
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
|
10-Q 2025-11-12 Open Filing |
Stale Filing | Inspect |
| PEW | GrabAGun Digital Holdings Inc. | Passing | 38.2% | 92,149,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| PHUN | Phunware, Inc. | Passing | 59.2% | 92,591,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-11 Open Filing |
Verified | Inspect |
| PLRX | PLIANT THERAPEUTICS, INC. | Passing | 61.3% | 137,500,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-11 Open Filing |
Verified | Inspect |
| PLTYF | Plastec Technologies, Ltd. | Passing | 95.1% | 5,314,249 |
Negative OCF
No Material 1Y Share Increase
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-15 Open Filing |
Verified | Inspect |
| PMN | ProMIS Neurosciences Inc. | Passing | 49.6% | 58,918,693 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-12 Open Filing |
Verified | Inspect |
| PXLW | PIXELWORKS, INC | Passing | 41.5% | 56,381,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| QFIN | Qfin Holdings, Inc. | Needs Review | 49.7% | 2,505,435,605 |
High NCAV Burn since the previous filing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-27 Open Filing |
Stale Filing | Inspect |
| RCON | Recon Technology, Ltd | Needs Review | 75.6% | 42,712,285 |
High NCAV Burn since the previous filing
Material 1Y Share Increase
+2 more
More statement observations
Negative OCF
latest reporting-period cash from operations < 0
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-10-15 Open Filing |
Stale Filing | Inspect |
| RDGT | Ridgetech Inc. | Needs Review | 81.2% | 24,860,757 |
Material 1Y Share Increase
Positive OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-07-28 Open Filing |
Stale Filing | Inspect |
| RKDA | Arcadia Biosciences, Inc. | Passing | 88.1% | 2,731,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| RMSG | Real Messenger Corp | Needs Review | 75.4% | 3,443,270 |
Negative OCF
Current Ratio > 1.5
|
20-F 2026-01-27 Open Filing |
Stale Filing | Inspect |
| RNA | Atrium Therapeutics, Inc. | Passing | 37.8% | 227,309,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| RR | RICHTECH ROBOTICS INC. | Needs Review | 42.1% | 322,839,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-02-12 Open Filing |
Stale Filing | Inspect |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | Passing | 74.3% | 17,440,481 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| SGLY | Singularity Future Technology Ltd. | Passing | 53.5% | 8,004,774 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| SLE | Super League Enterprise, Inc. | Passing | 38.2% | 10,648,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| SOHU | Sohu.com Ltd | Needs Review | 44.5% | 609,936,000 |
Negative OCF
NCAV Growing
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-03-12 Open Filing |
Stale Filing | Inspect |
| SONX | Sonendo, Inc. | Needs Review | 68.4% | 1,731,000 |
High NCAV Burn since the previous filing
Negative OCF
+3 more
More statement observations
High Debt
(short-term debt + long-term debt) / ordinary equity >= 50%
Current Ratio <= 1.5
current assets / current liabilities <= 1.5
Share Count Reduced
1Y share change <= -2% using the same share-count source
|
10-K 2025-03-26 Open Filing |
Stale Filing | Inspect |
| SRRE | SUNRISE REAL ESTATE GROUP INC | Passing | 86.7% | 36,111,154 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-20 Open Filing |
Verified | Inspect |
| STBXF | Starbox Group Holdings Ltd. | Needs Review | 99.9% | 1,969,890 |
High NCAV Burn since the previous filing
Negative OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-02-14 Open Filing |
Stale Filing | Inspect |
| SVUHF | SRIVARU Holding Ltd | Needs Review | 99.9% | 3,703,825 |
Negative OCF
Share Count Reduced
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-08-08 Open Filing |
Stale Filing | Inspect |
| TANH | TANTECH HOLDINGS LTD | Passing | 53.1% | 60,365,581 |
High NCAV Burn since the previous filing
Material 1Y Share Increase
+2 more
More statement observations
Negative OCF
latest reporting-period cash from operations < 0
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-14 Open Filing |
Verified | Inspect |
| TENX | TENAX THERAPEUTICS, INC. | Passing | 62.1% | 114,692,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-12 Open Filing |
Verified | Inspect |
| TGL | TREASURE GLOBAL INC | Passing | 96.8% | 11,185,147 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-20 Open Filing |
Verified | Inspect |
| TIL | Instil Bio, Inc. | Passing | 53.2% | 98,572,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| TNBI | Tanke Biosciences Corp | Needs Review | 93.9% | 6,598,431 |
High NCAV Burn since the previous filing
Positive OCF
+2 more
More statement observations
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2013-11-14 Open Filing |
Stale Filing | Inspect |
| TSPH | TuSimple Holdings Inc. | Needs Review | 94.3% | 716,047,000 |
Negative OCF
Low Debt
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2023-11-09 Open Filing |
Stale Filing | Inspect |
| TVRD | Tvardi Therapeutics, Inc. | Passing | 46.9% | 14,014,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-08 Open Filing |
Verified | Inspect |
| UPB | Upstream Bio, Inc. | Passing | 38.6% | 302,220,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| VGAS | Verde Clean Fuels, Inc. | Passing | 58.3% | 53,756,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-12 Open Filing |
Verified | Inspect |
| VINC | Vincerx Pharma, Inc. | Needs Review | 96.2% | 2,066,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2025-05-15 Open Filing |
Stale Filing | Inspect |
| VISN | Vistance Networks, Inc. | Needs Review | 41.0% | 2,475,300,000 |
Negative OCF
Low Debt
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-04-30 Open Filing |
Stale Filing | Inspect |
| VIVS | VivoSim Labs, INC. | Needs Review | 88.9% | 3,522,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-02-11 Open Filing |
Stale Filing | Inspect |
| VPG | Vishay Precision Group, Inc. | Needs Review | 99.4% | 126,731,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-12 Open Filing |
Needs Review | Inspect |
| VTEX | VTEX | Needs Review | 99.5% | 154,369,000 |
High NCAV Burn since the previous filing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-02-26 Open Filing |
Stale Filing | Inspect |
| VTGN | Vistagen Therapeutics, Inc. | Needs Review | 87.3% | 49,109,000 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-02-12 Open Filing |
Stale Filing | Inspect |
| WAFU | Wah Fu Education Group Ltd | Needs Review | 60.9% | 10,549,390 |
Negative OCF
Share Count Reduced
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2025-07-31 Open Filing |
Stale Filing | Inspect |
| WCT | Wellchange Holdings Co Ltd | Passing | 85.9% | 3,295,724 |
Negative OCF
Share Count Reduced
+2 more
More statement observations
Low Debt
(short-term debt + long-term debt) / ordinary equity < 20%
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-05-14 Open Filing |
Verified | Inspect |
| WETH | Wetouch Technology Inc. | Passing | 92.1% | 128,606,832 |
Positive OCF
Current Ratio > 1.5
|
10-Q 2026-05-15 Open Filing |
Verified | Inspect |
| WKSP | Worksport Ltd | Passing | 39.4% | 5,566,408 |
High NCAV Burn since the previous filing
Negative OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-05-13 Open Filing |
Verified | Inspect |
| WLGSF | WANG & LEE GROUP, Inc. | Needs Review | 99.9% | 1,607,723 |
High NCAV Burn since the previous filing
Material 1Y Share Increase
+2 more
More statement observations
Negative OCF
latest reporting-period cash from operations < 0
Current Ratio <= 1.5
current assets / current liabilities <= 1.5
|
20-F 2025-05-15 Open Filing |
Stale Filing | Inspect |
| WNW | Meiwu Technology Co Ltd | Needs Review | 98.4% | 19,464,478 |
High NCAV Burn since the previous filing
Positive OCF
+2 more
More statement observations
Share Count Reduced
1Y share change <= -2% using the same share-count source
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-17 Open Filing |
Stale Filing | Inspect |
| XBIT | XBiotech Inc. | Passing | 48.9% | 112,230,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-14 Open Filing |
Verified | Inspect |
| XXII | 22nd Century Group, Inc. | Passing | 99.6% | 11,978,000 |
Negative OCF
Current Ratio > 1.5
|
10-Q 2026-05-07 Open Filing |
Verified | Inspect |
| YAAS | Youxin Technology Ltd | Needs Review | 77.6% | 7,887,712 |
Negative OCF
Share Count Reduced
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-01-28 Open Filing |
Stale Filing | Inspect |
| YDKG | Yueda Digital Holding | Needs Review | 97.6% | 211,072,000 |
Positive OCF
Share Count Reduced
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
20-F 2026-04-30 Open Filing |
Stale Filing | Inspect |
| YOUL | Youlife Group Inc. | Needs Review | 72.2% | 67,190,965 |
Positive OCF
Current Ratio > 1.5
|
20-F 2026-04-30 Open Filing |
Stale Filing | Inspect |
| YYAI | AIRWA INC. | Needs Review | 41.4% | 49,662,450 |
High NCAV Burn since the previous filing
Positive OCF
+1 more
More statement observations
Current Ratio > 1.5
current assets / current liabilities; strong if > 1.5
|
10-Q 2026-03-17 Open Filing |
Stale Filing | Inspect |
Run ids, accessions, source notes, and Mary reason fragments for review.
| Ticker | Audit Note |
|---|---|
| AARD | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001193125-26-210675; mary_cik=0001774857; gnni_supporting_filing_date=2026-05-07; internal_discount=0.638061; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ABOS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-12; mary_accession=0001628280-26-034204; mary_cik=0001576885; gnni_supporting_filing_date=2026-05-12; internal_discount=0.825539; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ACET | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-20; mary_accession=0001720580-26-000042; mary_cik=0001720580; gnni_supporting_filing_date=2026-05-13; internal_discount=0.743414; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| ACON | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001683168-26-003822; mary_cik=0001635077; gnni_supporting_filing_date=2026-05-13; internal_discount=0.740761; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| AEI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001493152-26-023104; mary_cik=0001750106; gnni_supporting_filing_date=2026-05-14; internal_discount=0.366445; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| AQMS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001437749-26-017038; mary_cik=0001621832; gnni_supporting_filing_date=2026-05-14; internal_discount=0.380214; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ARTL | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001640334-26-000869; mary_cik=0001621221; gnni_supporting_filing_date=2026-05-14; internal_discount=0.673426; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ASNS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001213900-26-056772; mary_cik=0001141284; gnni_supporting_filing_date=2026-05-14; internal_discount=0.843899; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ATOS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-08; mary_accession=0001193125-26-213423; mary_cik=0001488039; gnni_supporting_filing_date=2026-05-08; internal_discount=0.360287; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| AVCRF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-06-16; mary_accession=0001641172-25-015266; mary_cik=0001355736; gnni_supporting_filing_date=2025-06-16; internal_discount=0.909488; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| BCYC | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-30; mary_accession=0001104659-26-052117; mary_cik=0001761612; gnni_supporting_filing_date=2026-04-30; internal_discount=0.510367; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| BDMD | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-24; mary_accession=0001104659-26-048641; mary_cik=0001982444; gnni_supporting_filing_date=2026-04-24; internal_discount=0.701651; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| BIYA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-30; mary_accession=0001213900-26-050223; mary_cik=0001944712; gnni_supporting_filing_date=2026-04-30; internal_discount=0.931889; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| BLMZF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-02-14; mary_accession=0001213900-25-014457; mary_cik=0001984014; gnni_supporting_filing_date=2025-02-14; internal_discount=0.91334; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| BRQSF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057706; mary_cik=0001650575; gnni_supporting_filing_date=2026-05-15; internal_discount=0.488478; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| BYAH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057152; mary_cik=0001986247; gnni_supporting_filing_date=2026-03-02; internal_discount=0.63281; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| CAMG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2015-05-20; mary_accession=0001264931-15-000204; mary_cik=0001419559; internal_discount=0.996737; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| CDTG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001731122-26-000740; mary_cik=0001793895; gnni_supporting_filing_date=2026-05-15; internal_discount=0.512017; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| CELZ | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-08; mary_accession=0001477932-26-002893; mary_cik=0001187953; gnni_supporting_filing_date=2026-05-08; internal_discount=0.578994; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| CISS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-22; mary_accession=0001193125-26-170448; mary_cik=0001951067; gnni_supporting_filing_date=2026-04-22; internal_discount=0.981176; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| CNTX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-06; mary_accession=0001628280-26-031267; mary_cik=0001842952; gnni_supporting_filing_date=2026-05-06; internal_discount=0.665154; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| CODX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001493152-26-023085; mary_cik=0001692415; gnni_supporting_filing_date=2026-05-14; internal_discount=0.694306; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| CRBU | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001619856-26-000036; mary_cik=0001619856; gnni_supporting_filing_date=2026-05-07; internal_discount=0.456103; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| CREG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057542; mary_cik=0000721693; gnni_supporting_filing_date=2026-05-15; internal_discount=0.999937; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| CYN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001213900-26-056821; mary_cik=0001874097; gnni_supporting_filing_date=2026-05-14; internal_discount=0.880918; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| DCGO | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-11; mary_accession=0001628280-26-033563; mary_cik=0001822359; gnni_supporting_filing_date=2026-05-11; internal_discount=0.392312; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| DDI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-31; mary_accession=0001628280-26-022395; mary_cik=0001799567; gnni_supporting_filing_date=2026-03-31; internal_discount=0.923645; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| DOYU | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-17; mary_accession=0001104659-26-044566; mary_cik=0001762417; gnni_supporting_filing_date=2026-04-17; internal_discount=0.509287; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| DTST | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001731122-26-000732; mary_cik=0001419951; gnni_supporting_filing_date=2026-05-15; internal_discount=0.386771; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ECIA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-11-13; mary_accession=0001079973-25-001709; mary_cik=0000930775; internal_discount=0.411985; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| EH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001193125-26-226608; mary_cik=0001759783; gnni_supporting_filing_date=2026-05-15; internal_discount=0.993741; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| EHTH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001333493-26-000027; mary_cik=0001333493; gnni_supporting_filing_date=2026-05-07; internal_discount=0.854925; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| EJH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-10-30; mary_accession=0001213900-25-104179; mary_cik=0001769768; gnni_supporting_filing_date=2025-10-30; internal_discount=0.973626; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| ENGN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-06-15; mary_accession=0001193125-26-270386; mary_cik=0001980845; gnni_supporting_filing_date=2026-03-09; internal_discount=0.529076; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ENLV | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-25; mary_accession=0001213900-26-033857; mary_cik=0001596812; gnni_supporting_filing_date=2026-03-25; internal_discount=0.687269; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| ENVB | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001493152-26-023353; mary_cik=0000890821; gnni_supporting_filing_date=2026-05-15; internal_discount=0.450765; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ESMC | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001628280-26-035533; mary_cik=0000862668; gnni_supporting_filing_date=2026-05-15; internal_discount=0.580347; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| EYPT | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001193125-26-211870; mary_cik=0001314102; gnni_supporting_filing_date=2026-05-07; internal_discount=0.847681; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| FBIO | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001104659-26-061233; mary_cik=0001429260; gnni_supporting_filing_date=2026-05-14; internal_discount=0.548032; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| FCHL | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-22; mary_accession=0001493152-26-024947; mary_cik=0002023796; gnni_supporting_filing_date=2026-05-15; internal_discount=0.728794; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| FCUV | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001683168-26-003903; mary_cik=0001590418; gnni_supporting_filing_date=2026-05-14; internal_discount=0.46072; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| FLNA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001437749-26-015664; mary_cik=0001069530; gnni_supporting_filing_date=2026-05-07; internal_discount=0.372598; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| FTFT | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057871; mary_cik=0001066923; gnni_supporting_filing_date=2026-05-15; internal_discount=0.628052; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| GENI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-17; mary_accession=0001193125-26-110749; mary_cik=0001834489; gnni_supporting_filing_date=2026-03-17; internal_discount=0.557937; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| GERN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-06; mary_accession=0000886744-26-000032; mary_cik=0000886744; gnni_supporting_filing_date=2026-05-06; internal_discount=0.996922; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| GLXG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-10-24; mary_accession=0001213900-25-102144; mary_cik=0001905920; gnni_supporting_filing_date=2025-10-24; internal_discount=0.687992; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| GMTH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-06; mary_accession=0001683168-26-001549; mary_cik=0002000762; gnni_supporting_filing_date=2026-03-06; internal_discount=0.991518; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| GNLN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001493152-26-023857; mary_cik=0001743745; gnni_supporting_filing_date=2026-05-15; internal_discount=0.51846; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| GNTA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-01; mary_accession=0001493152-26-014387; mary_cik=0001838716; gnni_supporting_filing_date=2026-04-01; internal_discount=0.350283; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| GTEC | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001213900-26-055798; mary_cik=0001735041; gnni_supporting_filing_date=2026-05-13; internal_discount=0.742506; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| GXAI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-19; mary_accession=0001213900-26-058659; mary_cik=0001895618; gnni_supporting_filing_date=2026-05-14; internal_discount=0.61105; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| HAO | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-10-20; mary_accession=0001213900-25-100369; mary_cik=0001954594; gnni_supporting_filing_date=2025-10-20; internal_discount=0.700871; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| HCAI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001213900-26-055775; mary_cik=0001958399; gnni_supporting_filing_date=2026-05-13; internal_discount=0.448177; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| HOLO | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-27; mary_accession=0001829126-26-002773; mary_cik=0001841209; gnni_supporting_filing_date=2026-03-27; internal_discount=0.93765; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| HUDI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-01-30; mary_accession=0001213900-26-010177; mary_cik=0001791725; gnni_supporting_filing_date=2026-01-30; internal_discount=0.800618; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| HXHX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-30; mary_accession=0001213900-26-050203; mary_cik=0001936817; gnni_supporting_filing_date=2026-04-30; internal_discount=0.902699; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| ILLMF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2023-03-09; mary_accession=0001171843-23-001562; mary_cik=0001861233; gnni_supporting_filing_date=2023-03-09; internal_discount=0.580404; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| IMA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001193125-26-212073; mary_cik=0001835579; gnni_supporting_filing_date=2026-05-07; internal_discount=0.576937; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| INAB | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001193125-26-212135; mary_cik=0001740279; gnni_supporting_filing_date=2026-05-07; internal_discount=0.537375; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| INBP | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-08; mary_accession=0001437749-26-015899; mary_cik=0001016504; gnni_supporting_filing_date=2026-05-08; internal_discount=0.486141; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| INFQ | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001193125-26-227206; mary_cik=0002007825; gnni_supporting_filing_date=2026-05-15; internal_discount=0.645851; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| INLF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-06; mary_accession=0001213900-26-024760; mary_cik=0001991592; gnni_supporting_filing_date=2026-03-06; internal_discount=0.876518; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| INVE | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001193125-26-223705; mary_cik=0001036044; gnni_supporting_filing_date=2026-05-14; internal_discount=0.494685; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| ITP | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-11-13; mary_accession=0001213900-25-110001; mary_cik=0001358190; gnni_supporting_filing_date=2025-11-13; internal_discount=0.831966; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| IXHL | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057227; mary_cik=0001873875; gnni_supporting_filing_date=2026-05-15; internal_discount=0.540529; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| IZM | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-10-24; mary_accession=0001213900-25-102243; mary_cik=0001854572; gnni_supporting_filing_date=2025-10-24; internal_discount=0.452765; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| JDZG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-10; mary_accession=0001104659-26-041971; mary_cik=0001976908; gnni_supporting_filing_date=2026-04-10; internal_discount=0.973427; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| JTAI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001493152-26-023101; mary_cik=0001861622; gnni_supporting_filing_date=2026-05-14; internal_discount=0.950936; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| KPRX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-08; mary_accession=0001372514-26-000047; mary_cik=0001372514; gnni_supporting_filing_date=2026-05-08; internal_discount=0.453061; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| KUBR | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-11-19; mary_accession=0001214659-25-016956; mary_cik=0001081834; gnni_supporting_filing_date=2025-11-19; internal_discount=0.986574; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| LAB | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-06; mary_accession=0001193125-26-208967; mary_cik=0001162194; gnni_supporting_filing_date=2026-05-06; internal_discount=0.463345; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| LENZ | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-11; mary_accession=0001815776-26-000037; mary_cik=0001815776; gnni_supporting_filing_date=2026-05-11; internal_discount=0.605359; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| LIANY | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2023-11-13; mary_accession=0001831283-23-000126; mary_cik=0001831283; gnni_supporting_filing_date=2023-11-13; internal_discount=0.979588; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| LIDR | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001437749-26-017094; mary_cik=0001818644; gnni_supporting_filing_date=2026-05-14; internal_discount=0.375893; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| LIFD | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001096906-26-000803; mary_cik=0001391135; gnni_supporting_filing_date=2026-05-15; internal_discount=0.61919; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| LIPO | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-11-14; mary_accession=0001753926-25-001805; mary_cik=0001347242; gnni_supporting_filing_date=2025-11-14; internal_discount=0.997722; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| LPCN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001493152-26-021637; mary_cik=0001535955; gnni_supporting_filing_date=2026-05-07; internal_discount=0.526164; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| LX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-29; mary_accession=0001193125-26-189256; mary_cik=0001708259; gnni_supporting_filing_date=2026-04-29; internal_discount=0.797735; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| MGX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-11; mary_accession=0001193125-26-216774; mary_cik=0001785279; gnni_supporting_filing_date=2026-05-11; internal_discount=0.656111; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| MI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-01; mary_accession=0001213900-26-050939; mary_cik=0001958713; gnni_supporting_filing_date=2026-05-01; internal_discount=0.942832; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| MLGO | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-01; mary_accession=0001829126-26-002991; mary_cik=0001800392; gnni_supporting_filing_date=2026-04-01; internal_discount=0.94424; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| MSAI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001104659-26-060325; mary_cik=0001863990; gnni_supporting_filing_date=2026-05-13; internal_discount=0.740985; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| MSN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-02-17; mary_accession=0001437749-26-004337; mary_cik=0000032621; gnni_supporting_filing_date=2026-02-17; internal_discount=0.626924; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| MTVA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001104659-26-061166; mary_cik=0001638287; gnni_supporting_filing_date=2026-05-14; internal_discount=0.346208; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| NEON | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001437749-26-016562; mary_cik=0000087050; gnni_supporting_filing_date=2026-05-13; internal_discount=0.504751; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| NNDM | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001193125-26-211930; mary_cik=0001643303; gnni_supporting_filing_date=2026-05-07; internal_discount=0.999339; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| NPK | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001437749-26-017365; mary_cik=0000080172; gnni_supporting_filing_date=2026-05-15; internal_discount=0.99647; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| NPWR | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-11; mary_accession=0001845437-26-000019; mary_cik=0001845437; gnni_supporting_filing_date=2026-05-11; internal_discount=0.751119; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| NSPR | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001493152-26-021636; mary_cik=0001433607; gnni_supporting_filing_date=2026-05-07; internal_discount=0.410254; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| NTCL | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-02-02; mary_accession=0001104659-26-008806; mary_cik=0001927578; gnni_supporting_filing_date=2026-02-02; internal_discount=0.996074; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| NVNO | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-06; mary_accession=0001493152-26-021490; mary_cik=0001661053; gnni_supporting_filing_date=2026-05-06; internal_discount=0.809202; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| NXTS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001493152-26-023107; mary_cik=0001789192; gnni_supporting_filing_date=2026-05-14; internal_discount=0.90879; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| OGEN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-08; mary_accession=0001493152-26-021967; mary_cik=0001174940; gnni_supporting_filing_date=2026-05-08; internal_discount=0.738097; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| OKUR | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-05; mary_accession=0001193125-26-206345; mary_cik=0001637715; gnni_supporting_filing_date=2026-05-05; internal_discount=0.804373; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| PBM | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-07-25; mary_accession=0001213900-25-067748; mary_cik=0001985062; gnni_supporting_filing_date=2025-06-25; internal_discount=0.684851; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| PETZ | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-20; mary_accession=0001213900-26-045630; mary_cik=0001684425; gnni_supporting_filing_date=2026-04-20; internal_discount=0.47829; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| PEVM | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-11-12; mary_accession=0001493152-25-021920; mary_cik=0001879848; gnni_supporting_filing_date=2025-11-12; internal_discount=0.993342; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| PEW | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001193125-26-221673; mary_cik=0002051380; gnni_supporting_filing_date=2026-05-13; internal_discount=0.381746; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| PHUN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-11; mary_accession=0001193125-26-216740; mary_cik=0001665300; gnni_supporting_filing_date=2026-05-11; internal_discount=0.592166; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| PLRX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-11; mary_accession=0001746473-26-000090; mary_cik=0001746473; gnni_supporting_filing_date=2026-05-11; internal_discount=0.613203; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| PLTYF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001104659-26-061965; mary_cik=0001433309; gnni_supporting_filing_date=2026-05-15; internal_discount=0.951308; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| PMN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-12; mary_accession=0001104659-26-059035; mary_cik=0001374339; gnni_supporting_filing_date=2026-05-12; internal_discount=0.496203; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| PXLW | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001040161-26-000032; mary_cik=0001040161; gnni_supporting_filing_date=2026-05-14; internal_discount=0.414931; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| QFIN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-27; mary_accession=0001104659-26-049501; mary_cik=0001741530; gnni_supporting_filing_date=2026-04-27; internal_discount=0.496866; mary_reason=Required return hurdle = 8.98% (10Y_TBILL_PLUS_SPREAD). | After-SBC owner FCF yield passes in: 3y, 5y. | TTM after-SBC owner FCF yield also passes the hurdle. | ROIC capital-efficiency q=15.62% set the curve spread at 3.41%; owner FCF yi...; source requires review |
| RCON | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-10-15; mary_accession=0001104659-25-099502; mary_cik=0001442620; gnni_supporting_filing_date=2025-10-15; internal_discount=0.756162; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| RDGT | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-07-28; mary_accession=0001213900-25-067924; mary_cik=0001856084; gnni_supporting_filing_date=2025-07-28; internal_discount=0.81159; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| RKDA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001193125-26-223990; mary_cik=0001469443; gnni_supporting_filing_date=2026-05-14; internal_discount=0.881; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| RMSG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-01-27; mary_accession=0001493152-26-003686; mary_cik=0001983324; gnni_supporting_filing_date=2025-07-31; internal_discount=0.753564; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| RNA | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001193125-26-224243; mary_cik=0002093101; gnni_supporting_filing_date=2026-05-14; internal_discount=0.377659; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| RR | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-02-12; mary_accession=0001213900-26-015097; mary_cik=0001963685; gnni_supporting_filing_date=2026-02-12; internal_discount=0.421209; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| RVPH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001437749-26-016762; mary_cik=0001742927; gnni_supporting_filing_date=2026-05-13; internal_discount=0.742918; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| SGLY | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001213900-26-056602; mary_cik=0001422892; gnni_supporting_filing_date=2026-05-14; internal_discount=0.535317; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| SLE | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001437749-26-017431; mary_cik=0001621672; gnni_supporting_filing_date=2026-05-15; internal_discount=0.381561; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| SOHU | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-12; mary_accession=0001193125-26-102990; mary_cik=0001734107; gnni_supporting_filing_date=2026-03-12; internal_discount=0.4448; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| SONX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-03-26; mary_accession=0000950170-25-045214; mary_cik=0001407973; gnni_supporting_filing_date=2025-03-26; internal_discount=0.684008; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| SRRE | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-20; mary_accession=0001104659-26-064441; mary_cik=0001083490; gnni_supporting_filing_date=2026-04-17; internal_discount=0.866844; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| STBXF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-02-14; mary_accession=0001493152-25-006520; mary_cik=0001914818; internal_discount=0.998994; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| SVUHF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-08-08; mary_accession=0001641172-25-022759; mary_cik=0001973368; gnni_supporting_filing_date=2025-08-08; internal_discount=0.998837; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| TANH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001477932-26-003132; mary_cik=0001588084; gnni_supporting_filing_date=2026-05-14; internal_discount=0.531357; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| TENX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-12; mary_accession=0001193125-26-219383; mary_cik=0000034956; gnni_supporting_filing_date=2026-05-12; internal_discount=0.621132; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| TGL | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-20; mary_accession=0001213900-26-059507; mary_cik=0001905956; gnni_supporting_filing_date=2026-02-23; internal_discount=0.968239; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| TIL | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001789769-26-000045; mary_cik=0001789769; gnni_supporting_filing_date=2026-05-15; internal_discount=0.532145; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| TNBI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2013-11-14; mary_accession=0001213900-13-006510; mary_cik=0001452011; gnni_supporting_filing_date=2013-11-14; internal_discount=0.939422; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| TSPH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2023-11-09; mary_accession=0001628280-23-037959; mary_cik=0001823593; gnni_supporting_filing_date=2023-11-09; internal_discount=0.94272; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| TVRD | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-08; mary_accession=0001104659-26-057528; mary_cik=0001346830; gnni_supporting_filing_date=2026-05-08; internal_discount=0.469145; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| UPB | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001193125-26-220584; mary_cik=0002022626; gnni_supporting_filing_date=2026-05-13; internal_discount=0.38597; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| VGAS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-12; mary_accession=0001628280-26-033746; mary_cik=0001841425; gnni_supporting_filing_date=2026-05-12; internal_discount=0.583274; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| VINC | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-05-15; mary_accession=0001193125-25-120762; mary_cik=0001796129; internal_discount=0.961997; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| VISN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-30; mary_accession=0001193125-26-193963; mary_cik=0001517228; gnni_supporting_filing_date=2026-04-30; internal_discount=0.410123; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| VIVS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-02-11; mary_accession=0001193125-26-046520; mary_cik=0001497253; gnni_supporting_filing_date=2026-02-11; internal_discount=0.888928; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| VPG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-12; mary_accession=0001437749-26-016261; mary_cik=0001487952; gnni_supporting_filing_date=2026-05-12; internal_discount=0.994276; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| VTEX | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-02-26; mary_accession=0001193125-26-076504; mary_cik=0001793663; gnni_supporting_filing_date=2026-02-26; internal_discount=0.995227; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| VTGN | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-02-12; mary_accession=0001628280-26-007718; mary_cik=0001411685; gnni_supporting_filing_date=2026-02-12; internal_discount=0.873111; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| WAFU | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-07-31; mary_accession=0001213900-25-069961; mary_cik=0001716770; gnni_supporting_filing_date=2025-07-31; internal_discount=0.609379; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| WCT | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001213900-26-055994; mary_cik=0001990251; gnni_supporting_filing_date=2026-05-14; internal_discount=0.859191; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| WETH | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057874; mary_cik=0001826660; gnni_supporting_filing_date=2026-05-15; internal_discount=0.920584; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| WKSP | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-13; mary_accession=0001493152-26-022706; mary_cik=0001096275; gnni_supporting_filing_date=2026-05-13; internal_discount=0.393701; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| WLGSF | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2025-05-15; mary_accession=0001641172-25-010670; mary_cik=0001899658; gnni_supporting_filing_date=2025-05-15; internal_discount=0.99892; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| WNW | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-17; mary_accession=0001493152-26-017159; mary_cik=0001787803; gnni_supporting_filing_date=2026-04-17; internal_discount=0.983846; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| XBIT | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-14; mary_accession=0001171843-26-003419; mary_cik=0001626878; gnni_supporting_filing_date=2026-05-14; internal_discount=0.48929; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| XXII | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-07; mary_accession=0001104659-26-056615; mary_cik=0001347858; gnni_supporting_filing_date=2026-05-07; internal_discount=0.995501; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot. |
| YAAS | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-01-28; mary_accession=0001493152-26-004040; mary_cik=0001964946; gnni_supporting_filing_date=2026-01-28; internal_discount=0.775928; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| YDKG | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-30; mary_accession=0001213900-26-050194; mary_cik=0001413745; gnni_supporting_filing_date=2026-04-30; internal_discount=0.976424; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| YOUL | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-04-30; mary_accession=0001213900-26-050196; mary_cik=0002028177; gnni_supporting_filing_date=2026-04-30; internal_discount=0.721571; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
| YYAI | mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-03-17; mary_accession=0001493152-26-010626; mary_cik=0001674440; gnni_supporting_filing_date=2026-03-17; internal_discount=0.413633; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review |
Limits stay visible because they are part of the record.
Medium | Share Count
The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.
Affected: AARD, ABOS, ACET, ACON, AEI, AQMS, ARTL, ASNS, ATOS, AVCRF, BCYC, BDMD and 133 more
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Affected: AARD, ABOS, ACET, ACON, AEI, AQMS, ARTL, ASNS, ATOS, AVCRF, BCYC, BDMD and 133 more
High | Filing
Some rows do not have a verified direct filing URL in the local official filing cache.
Affected: ACET, BYAH, FCHL, GXAI, VPG
Medium | Filing
Some rows are based on older filing data and require manual freshness review.
Affected: AVCRF, BCYC, BDMD, BIYA, BLMZF, CAMG, CISS, DDI, DOYU, ECIA, EJH, ENLV and 47 more
Medium | Other
Mary screening run 96f10914845d4a63bf1f2ca5985451b2 finished with status PARTIAL_SUCCESS; publication uses Mary's passed net-net list and marks source limitations in-row.
Affected:
GNNI is the discovery path for source-linked net-net candidates.
Net-net screening compares company valuation context with net current asset value, commonly abbreviated NCAV. In this pilot, NCAV is treated as current assets less total liabilities, using parsed values tied back to official filings where available.
Mary may use market-derived inputs internally to determine whether a candidate passed the net-net screen. Public issues may show Mary's internal discount calculation, but do not publish the raw market-data fields behind it.
The U.S. Pilot covers U.S. listed candidates from Mary's latest deterministic net-net screening output. The stale GNNI NCAV shortlist is not used as a publication gate.
This product does not provide investment recommendations, portfolio advice, security selection instructions, or complete company research. Passing means a candidate appears in the deterministic net-net screen and requires inspection.
Direct filing links matter because every candidate should be inspectable from source evidence. When source evidence is missing or stale, the row must say so.
Issue 000 is the baseline. Issue 015 compares the current register with gnni-us-issue-014.
Entered and exited are register states, not recommendations. Unchanged passing companies remain in the Register and are not repeated in What Changed.